Yes, ESI is likely to help this patient with S1 radiculopathy from L5-S1 disc herniation after failed conservative treatment.
For a patient with confirmed S1 radiculopathy from a 4-mm L5-S1 disc bulge who has failed 6 weeks of optimal conservative treatment, a fluoroscopically-guided transforaminal epidural steroid injection (TFESI) is recommended and likely to provide significant short-term pain relief and functional improvement.
Guideline-Based Recommendation
The 2021 ASIPP guidelines provide a strong recommendation in favor of fluoroscopically-guided lumbar transforaminal epidural injections for chronic spine pain associated with disc herniation 1. This directly applies to your clinical scenario. However, the 2025 BMJ guideline presents a contrasting view, recommending against epidural injections for chronic radicular spine pain 1. This creates a clinical dilemma that requires careful interpretation.
Resolving the Guideline Conflict
The key distinction lies in understanding what these guidelines actually evaluated:
- The 2025 BMJ guideline's recommendation against ESI was based on very low to low certainty evidence and primarily addressed chronic axial (non-radicular) spine pain 1
- The 2023 synthesis of guidelines confirms that most recommendations against ESI pertained to axial, non-radicular low back pain, not radiculopathy 2
- For radiculopathy specifically, the evidence base is substantially different and more favorable
Your patient has radiculopathy (S1 distribution pain with disc herniation), not isolated axial back pain, which places them in a different evidence category where ESI shows benefit.
Supporting Research Evidence
The most recent high-quality evidence strongly supports ESI for radiculopathy:
- A 2026 prospective study demonstrated that TFESI provided 70% reduction in leg pain and 60% reduction in back pain at early time points (1-6 weeks) compared to oral steroids, with faster functional recovery 3
- A 2025 AAN systematic review of 90 RCTs found ESI probably reduces short-term pain (success rate difference -24%, NNT=4) and disability (success rate difference -16%, NNT=6) in lumbar radiculopathies 4
- A 2026 retrospective cohort of 252 patients showed 64.3% achieved >50% pain improvement at 3 months, with 74.2% success for nocturnal pain and only 12% requiring subsequent surgery 5
Clinical Algorithm for Your Patient
Given your specific clinical scenario:
Confirm radiculopathy diagnosis: ✓ You have S1 distribution pain (right shin-ankle), imaging confirmation (4-mm L5-S1 disc), and clinical signs consistent with nerve root involvement
Verify failed conservative treatment: ✓ Six weeks of optimal non-operative treatment completed
Proceed with fluoroscopically-guided TFESI at L5-S1: This is the appropriate next step
Expected outcomes:
Technical Considerations
Route selection: For S1 radiculopathy from L5-S1 disc herniation, both caudal ESI and TFESI are equally effective (77% vs 73% success rates), though TFESI may provide slightly faster onset 6. TFESI has the theoretical advantage of delivering medication directly to the pathology site in the anterior epidural space 8.
Timing: The evidence suggests ESI is most effective when performed after conservative treatment failure but before symptoms become chronic (your patient at 6 weeks is in an optimal window).
Important Caveats
- Short-term vs long-term: The most robust benefits occur in the first 3-6 months. By 12 weeks, outcomes may converge with other treatments 3
- Not a cure: ESI provides symptomatic relief and may facilitate rehabilitation, but does not alter the natural history of disc herniation
- Risks: Small risk of infection, dural puncture, and extremely rare catastrophic complications (paralysis, death) 1. These risks are acceptable given the potential 4-point NNT for pain relief
- Surgical consideration: If ESI fails or provides only temporary relief, this patient may ultimately require surgical evaluation, particularly given the presence of muscle atrophy (which suggests more severe or prolonged nerve compression)
Red Flag: Muscle Atrophy
The presence of lumbar muscle atrophy warrants careful consideration. Progressive motor weakness or significant atrophy may indicate more severe nerve compression that could benefit from earlier surgical intervention rather than prolonged conservative management. Ensure you document motor strength testing and consider earlier surgical consultation if there is objective motor weakness (not just atrophy from disuse).
Bottom line: Proceed with fluoroscopically-guided TFESI at L5-S1, but maintain a lower threshold for surgical referral given the atrophy finding.